drugset / Trial / NCT02022722

Trigger Point Injections and Pelvic Rehabilitation for the Treatment of Pelvic Floor Myalgia and Sexual Pain

NCT02022722

RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to evaluate which treatment option for pelvic floor pain allows for improved sexual function.

Timeline

Start
2013-08
Primary completion
2014-04
Completion
2014-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 0.5 % Intramuscular
Comparator Triamcinolone Acetonide Other / unclassified 40 mg Intramuscular

Indications

No indication recorded.